Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.

A. Kerbrat 1, 2 S Hamonic 3 E Leray 2 I Tron 4 Gilles Edan 2, 5, 1 J Yaouanq 2
1 VisAGeS - Vision, Action et Gestion d'informations en Santé
INSERM - Institut National de la Santé et de la Recherche Médicale : U746, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE
Abstract : Multiple sclerosis (MS) prognosis remains a challenge for both patients and physicians. Complementary to natural history studies, updated population-based data from the first event suggestive of MS, at the time of the first approved disease modifying drug (DMD), are needed. Our objective was to provide a 10-year history of MS from clinical onset at time of first approved DMDs in a population-based cohort.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01103117
Contributor : Gilles Edan <>
Submitted on : Wednesday, January 14, 2015 - 10:01:37 AM
Last modification on : Monday, March 4, 2019 - 2:08:32 PM

Links full text

Identifiers

Citation

A. Kerbrat, S Hamonic, E Leray, I Tron, Gilles Edan, et al.. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.. European Journal of Neurology, Wiley, 2015, 22 (3), pp.507-e35. ⟨10.1111/ene.12600⟩. ⟨inserm-01103117⟩

Share

Metrics

Record views

328